Johnson & Johnson (JNJ) Appoints UCLA Med School Dean Washington to Board
Tweet
Share
E-mailGet Alerts JNJ Hot Sheet
Join SI Premium – FREE
On November 6, 2012, Dr. A. Eugene Washington, M.D., M.Sc., was appointed to the Board of Directors of Johnson & Johnson (NYSE: JNJ).
Dr. Washington serves as Vice Chancellor of Health Sciences and Dean of the David Geffen School of Medicine at the University of California, Los Angeles (UCLA), as well as Chief Executive Officer of the UCLA Health System. He is also a distinguished professor of Gynecology and Health Policy at UCLA. As a non-employee director of the Company, Dr. Washington will receive compensation as described in the “Director Compensation” section of the Company's 2012 Proxy Statement. The Company's press release announcing the appointment is attached to this Report as Exhibit 99.1.
Dr. Washington serves as Vice Chancellor of Health Sciences and Dean of the David Geffen School of Medicine at the University of California, Los Angeles (UCLA), as well as Chief Executive Officer of the UCLA Health System. He is also a distinguished professor of Gynecology and Health Policy at UCLA. As a non-employee director of the Company, Dr. Washington will receive compensation as described in the “Director Compensation” section of the Company's 2012 Proxy Statement. The Company's press release announcing the appointment is attached to this Report as Exhibit 99.1.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Johnson & Johnson drug for rare blood disorder
- Marqeta names Eugenia Gibbons as chief product officer
- FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
